FDA’s Position on Over-the-Counter (OTC) Use of Drugs for Asthma and Allergies: Serving the Patient and Public Health
Chowdhury BA.
RDD Europe 2015. Volume 1, 2015: 213-214.
Abstract:
The topic of switching drugs and drug products from prescription to non-prescription (over- the-counter (OTC)) status in the United States will be reviewed from scientific, regulatory and historic perspectives, especially as it relates to inhaled products and the continued assurance of good public health policy.
I have a subscription
Log in for instant access.
I do not have a subscription
Purchase Article (in PDF format)
